Table 2 Outcomes of the elaboration (EC) and validation (VC) cohorts
EC (n = 323) | VC (n = 534) | ||||
|---|---|---|---|---|---|
n | % | n | % | p a | |
Hospitalization durationb | 12.6 [1–143] | 12.9 [1–91] | 0.94 | ||
Renal biopsy | 38 | 12 | 76 | 14 | 0.59 |
Extrarenal depuration requirement | 76 | 24 | 132 | 25 | 0.84 |
Death | 50 | 16 | 48 | 9 | 0.15 |
sepsis | 23 | 46 | 21 | 44 | 0.74 |
cardio-pulmonary failure | 10 | 21 | 13 | 27 | 0.32 |
haemorrage | 7 | 14 | 3 | 6 | 0.06 |
multiorgan failure | 7 | 14 | 6 | 13 | 0.75 |
other causes of death | 3 | 7 | 5 | 11 | 0.36 |
Complete renal recovery c | 179 | 65 | 219 | 45 | 0.004 |
Chronic dialysis | 7 | 3 | 48 | 10 | 0.03 |
Destination | |||||
home | 149 | 46 | 307 | 57 | 0.21 |
other conventional unit | 77 | 24 | 101 | 19 | 0.21 |
rehabilitation center | 45 | 14 | 61 | 11 | 0.44 |
ICU | 3 | 1 | 17 | 3 | 0.21 |